Cordis Corp., a Johnson & Johnson (NYSE:JNJ) subsidiary, said it inked an exclusive deal to distribute TriReme Medical’s Chocolate PTA balloon catheter.

The Chocolate PTA device is designed to treat peripheral artery disease

Pleasanton, Calif.-based TriReme won 510(k) clearance from the FDA for the Chocolate PTA device in December 2011. An expanded indication for additional sizes followed in July 2012.

“Cordis is pleased to have the opportunity to partner with TriReme Medical on this exciting and highly differentiated technology,” Cordis Corp. president Celine Martin said in prepared remarks. “As a leader in endovascular technologies, this agreement represents our continuing commitment to identifying optimal solutions for patients suffering from peripheral artery disease.”